Format

Send to

Choose Destination
Diabetes Res Clin Pract. 2019 Aug 1:107806. doi: 10.1016/j.diabres.2019.107806. [Epub ahead of print]

The future is now: SGLT2 inhibitors and type 1 diabetes - What about exercise?

Author information

1
Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria. Electronic address: max.eckstein@medunigraz.at.
2
Department of Molecular and Cellular Sport Medicine, Institute of Cardiovascular Research and Sport Medicine, German Sport University Cologne, Cologne, Germany.
3
Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
4
Exercise Physiology, Training Therapy & Training Research Group, Institute of Sports Sciences, University of Graz, Graz, Austria.

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center